It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Rational Pharmacotherapy in CardiologyAnticoagulants in acute coronary syndrome

Anticoagulants in acute coronary syndrome

I.A. Latfullin, A.A. Podolskaya*

Chair of Internal Medicine N 2, Kazan State Medical University, ul. Butlerova 49, 420012 Kazan, Republic Tatarstan, Russia

Clinical efficacy of unfractionated and low molecular heparins in acute coronary syndrome is discussed. New synthetic heparin derivative fondaparinux (Arixtra) is focused. Author’s brief experience of fondaparinux clinical implementation is presented.

Key words: acute coronary syndrome, anticoagulants, fondaparinux.

Rational Pharmacother. Card. 2009;3:71-75

*Corresponding author: raushania13 (at) rambler.ru


Download free full text (PDF)

© 2007 — 2014 «Rational Pharmacotherapy in Cardiology»
«Stolichnaya Izdatelskaya Kompaniya»

ISSN 1819-6446(Print) ISSN 2225-3653 (Online)